- Home
- TYG vs EBS Comparison
TYG vs EBS Comparison
Compare TYG & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYG
- EBS
- Stock Information
- Founded
- TYG 2003
- EBS 1998
- Country
- TYG United States
- EBS United States
- Employees
- TYG N/A
- EBS N/A
- Industry
- TYG Investment Managers
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- TYG Finance
- EBS Health Care
- Exchange
- TYG Nasdaq
- EBS Nasdaq
- Market Cap
- TYG 469.0M
- EBS 459.6M
- IPO Year
- TYG N/A
- EBS 2006
- Fundamental
- Price
- TYG $44.99
- EBS $9.48
- Analyst Decision
- TYG
- EBS Strong Buy
- Analyst Count
- TYG 0
- EBS 2
- Target Price
- TYG N/A
- EBS $14.00
- AVG Volume (30 Days)
- TYG 30.4K
- EBS 1.6M
- Earning Date
- TYG 01-01-0001
- EBS 11-06-2024
- Dividend Yield
- TYG 6.94%
- EBS N/A
- EPS Growth
- TYG N/A
- EBS N/A
- EPS
- TYG 9.77
- EBS N/A
- Revenue
- TYG $13,618,248.00
- EBS $1,125,500,000.00
- Revenue This Year
- TYG N/A
- EBS $7.98
- Revenue Next Year
- TYG N/A
- EBS $6.62
- P/E Ratio
- TYG $4.60
- EBS N/A
- Revenue Growth
- TYG N/A
- EBS 2.05
- 52 Week Low
- TYG $27.44
- EBS $1.42
- 52 Week High
- TYG $45.34
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- TYG 75.29
- EBS 51.20
- Support Level
- TYG $42.26
- EBS $8.12
- Resistance Level
- TYG $45.34
- EBS $9.78
- Average True Range (ATR)
- TYG 0.79
- EBS 0.89
- MACD
- TYG 0.24
- EBS -0.13
- Stochastic Oscillator
- TYG 93.59
- EBS 35.16
About TYG Tortoise Energy Infrastructure Corporation
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.